VM

Vanessa Malier

Executive in biotech, pharma industry and investment in healthcare

Greater Paris Metropolitan Region

Investor
VC

Invests in

Locations:

Paris, France

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Strategy
Cross-functional Team Leadership
Business Development
Pharmaceutical Industry
Management
Product Development
Biotechnology
Clinical Development
Marketing Strategy
Venture Capital

Education

  • DEA

    Institut Pasteur, Paris

    (1996 - 1997)

  • Ecole Normale Supérieure de Cachan

    (1993 - 1997)

Investments

Step Pharma

Seed

Total Funding: $61M

IO Biotech

Series B

Total Funding: $150M

Corlieve Therapeutics

Seed

Total Funding:

Work Experience

Kurma Partners

2013 - 2023

  • Managing Partner

    2015 - 2023

    Kurma Partners/Eurazeo is a venture capital firm with €700m in asset under managment. I invested in and served on the Board of Asceneuron, Corlieve as a Chairman, acquired by uniQure, IO Biotech (IOBT), Step Pharma as a Chairman then Board member, Vivet Therapeutics and Xeltis.

  • Partner

    2013 - 2014

Ipsen

2003 - 2013

  • Vice President, R&D Strategic Planning

    2011 - 2013

  • Senior Director, Corporate Business Development

    2011 - 2011

  • Director, Corporate Business Development Oncology

    2008 - 2011

  • Adenuric Project Leader & International Product Manager, Corporate Strategic Marketing

    2005 - 2008

  • GastroEnterology Strategy Team Leader

    2004 - 2005

  • Strategic Advisor to the CEO

    2003 - 2005

DAS, Inc.

1999 - 2003

  • Business Development Manager

    1999 - 2003

CDC Entreprises Innovation

1998 - 1999

  • Analyst - Health Care

    1998 - 1999